We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
+6.76%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$424M
AUM Growth
+$18.8M
Cap. Flow
-$6.82M
Cap. Flow %
-1.61%
Top 10 Hldgs %
15.99%
Holding
311
New
46
Increased
58
Reduced
107
Closed
45

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$1.03M
2
MCD icon
McDonald's
MCD
+$757K
3
CL icon
Colgate-Palmolive
CL
+$417K
4
GLW icon
Corning
GLW
+$349K
5
WPC icon
W.P. Carey
WPC
+$342K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$990K
2
TIF
Tiffany & Co.
TIF
+$591K
3
ADBE icon
Adobe
ADBE
+$473K
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$431K
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$429K

Sector Composition

Rank Sector Weight
1 Technology 18.53%
2 Industrials 16.81%
3 Healthcare 10.71%
4 Consumer Discretionary 7.02%
5 Financials 6.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
51
Apple
AAPL
$4.8T
$2.13M 0.5%
29,024
-2,148
-7% -$138K
AKBA icon
52
Akebia Therapeutics
AKBA
$343M
$1.98M 0.47%
312,609
– –
ABMD
53
DELISTED
Abiomed Inc
ABMD
$1.89M 0.45%
11,072
-2,111
-16% -$391K
OTTR icon
54
Otter Tail
OTTR
$3.83B
$1.89M 0.45%
36,774
-1,866
-5% -$96.8K
BA icon
55
Boeing
BA
$165B
$1.88M 0.44%
5,781
-161
-3% -$57K
VER
56
DELISTED
VEREIT, Inc.
VER
$1.84M 0.43%
39,892
+1,156
+3% +$55.4K
KLAC icon
57
KLA
KLAC
$271B
$1.83M 0.43%
102,500
-9,140
-8% -$153K
SLP icon
58
Simulations Plus
SLP
$368M
$1.82M 0.43%
62,459
+3,759
+6% +$127K
EQR icon
59
Equity Residential
EQR
$25.8B
$1.8M 0.43%
22,269
-1,301
-6% -$111K
SNY icon
60
Sanofi
SNY
$105B
$1.8M 0.43%
35,880
-2,149
-6% -$101K
SPG icon
61
Simon Property Group
SPG
$74B
$1.69M 0.4%
11,359
+898
+9% +$135K
DUK icon
62
Duke Energy
DUK
$98.1B
$1.66M 0.39%
18,152
-759
-4% -$69.6K
LMT icon
63
Lockheed Martin
LMT
$117B
$1.64M 0.39%
4,212
-579
-12% -$222K
BXMT icon
64
Blackstone Mortgage Trust
BXMT
$2.82B
$1.64M 0.39%
44,038
-3,088
-7% -$112K
CVS icon
65
CVS Health
CVS
$137B
$1.62M 0.38%
21,809
-415
-2% -$29.1K
GILD icon
66
Gilead Sciences
GILD
$165B
$1.61M 0.38%
24,826
-2,052
-8% -$134K
NEE icon
67
NextEra Energy
NEE
$184B
$1.59M 0.37%
26,248
-1,460
-5% -$85.2K
GNRC icon
68
Generac Holdings
GNRC
$12.6B
$1.57M 0.37%
15,660
+1,421
+10% +$132K
BMY icon
69
Bristol-Myers Squibb
BMY
$123B
$1.57M 0.37%
24,449
+18,008
+280% +$1.03M
VRNS icon
70
Varonis Systems
VRNS
$5.45B
$1.56M 0.37%
60,189
+4,005
+7% +$95.1K
PH icon
71
Parker-Hannifin
PH
$120B
$1.53M 0.36%
7,456
-1,231
-14% -$239K
KEY icon
72
KeyCorp
KEY
$25.2B
$1.53M 0.36%
75,812
-3,282
-4% -$61.9K
SAFT icon
73
Safety Insurance
SAFT
$1.08B
$1.51M 0.36%
16,285
-591
-4% -$57.6K
XOM icon
74
ExxonMobil
XOM
$615B
$1.5M 0.35%
21,552
-2,659
-11% -$184K
T icon
75
AT&T
T
$153B
$1.5M 0.35%
50,889
-3,055
-6% -$88.2K
1 2
3
4 5

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
TFM
TFC Financial Management Boston, Massachusetts $812M AUM 17.34% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $818M AUM 13.48% 1-Year Est. Return

Stanley-Laman Group's Q4 2019 Portfolio in Review

As of Q4 2019, Stanley-Laman Group held 311 positions worth $424M, up 4.6% from $405M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Stanley-Laman Group's Q4 2019 filing shows 46 new, 58 increased, 107 reduced and 45 closed positions. Its largest new stake was McDonald's: 3,817 shares worth $754K. The largest sale was Celgene Corp, an estimated $990K.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Industrials and Healthcare.

  • Stanley-Laman Group's largest Q4 2019 buy was McDonald's: 3,817 shares worth $754K.
  • Stanley-Laman Group added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.03M increase.
  • Stanley-Laman Group's biggest Q4 2019 reduction was Tiffany & Co., cutting an estimated $591K.
  • Stanley-Laman Group fully exited Celgene Corp in Q4 2019, selling an estimated $990K.
  • Stanley-Laman Group's ten largest holdings make up 16% of its $424M portfolio in Q4 2019.
  • Stanley-Laman Group opened 46 new positions and closed 45 in Q4 2019.
  • Stanley-Laman Group's portfolio value rose 4.6% quarter-over-quarter to $424M.

Based on Stanley-Laman Group's 13F filing for Q4 2019, filed 4 Feb 2020.